Boyang Liu

Years Active: 2020-2022
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Wenhui Tang, Ningbo Xu, Jian Zhou, Zhenyan He, Cameron Lenahan, Chenyang Wang, Huangyi Ji, Boyang Liu, Yujiao Zou, Huijun Zeng, Hongbo Guo
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma. Cell death discovery 8 (1) (2022)
Wenhui Tang, Ningbo Xu, Jian Zhou, Zhenyan He, Cameron Lenahan, Chenyang Wang, Huangyi Ji, Boyang Liu, Yujiao Zou, Huijun Zeng, Hongbo Guo
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma. Cell death discovery 8 (1) (2022)
Wenhui Tang, Ningbo Xu, Jian Zhou, Zhenyan He, Cameron Lenahan, Chenyang Wang, Huangyi Ji, Boyang Liu, Yujiao Zou, Huijun Zeng, Hongbo Guo
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma. Cell death discovery 8 (1) (2022)
Wenhui Tang, Ningbo Xu, Jian Zhou, Zhenyan He, Cameron Lenahan, Chenyang Wang, Huangyi Ji, Boyang Liu, Yujiao Zou, Huijun Zeng, Hongbo Guo
ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma. Cell death discovery 8 (1) (2022)
Boyang Liu, Jian Zhou, Chenyang Wang, Yajie Chi, Quantang Wei, Zhao Fu, Changlin Lian, Qiongzhen Huang, Chenxin Liao, Zhao Yang, Huijun Zeng, Ningbo Xu, Hongbo Guo
LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma. Cell death & disease 11 (5) (2020)

Boyang Liu.css-eqlu8i{font-size:small;padding-left:4px;}